Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Growth Noted in French Laboratory Market

By Labmedica staff writers
Posted on 13 Apr 2006
The Interprofessional Committee of Laboratory Suppliers (CIFL, Paris, France) has announced that the laboratory market in France increased by 2.6 % in the year 2005.

The CIFL is a professional association comprising 167 laboratory suppliers representing more than 80% of the laboratory market. More...
At the general assembly of the association, members were presented with a positive analysis of the laboratory market in France. The upturn was mainly noticeable in the fourth quarter, indicating a recovery of investment.
During the two previous years there had been a drop in activity, closely linked to relocation in the chemistry and pharmacy sectors, and to a freeze in public expenditures.

The results are supported by a recent market survey, conducted by CIFL together with Alcimed (Paris, France; www.alcimed.com), which forecasts a slight expansion in activity in 2006 and 2007. Alcimed is a strategy and marketing consulting firm specializing in biotechnologies, health, food, and cosmetics.

However, whereas biotechnologies recorded an overall increase of more than 6%, the analytical chemistry sector struggled to achieve a 1% growth. Some sectors remain sensitive in this market of around 1.3 million euros, particularly the largest ones such as pharmacy and chemistry, while the environment, cosmetics, and public laboratory sector show sustained vitality.

Within work groups or commissions, CIFL members deal with all topics that can influence the evolution of the laboratory profession. The main objective of CIFL is the promotion of the laboratory profession, and its greatest success in this area has been the Forum Labo (Paris, France) event.





Related Links:
CIFL
Alcimed

Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hybrid Pipette
SWITCH
New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.